DISTRIBUTION OF CYTOCHROMES-P-450, CYTOCHROME-B5, AND NADPH-CYTOCHROME-P-450 REDUCTASE IN AN ENTIRE HUMAN LIVER

被引:39
作者
WATKINS, PB
MURRAY, SA
THOMAS, PE
WRIGHTON, SA
机构
[1] RUTGERS STATE UNIV,COLL MED,COLL PHARM,PISCATAWAY,NJ 08855
[2] MED COLL WISCONSIN,DEPT PHARMACOL,MILWAUKEE,WI 53226
关键词
D O I
10.1016/0006-2952(90)90052-M
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In rat liver there appear to be significant differences between lobes in the concentration of individual cytochrome P-450 isozymes (Sumner and Lodola, Biochem Pharmacol 36: 391-393, 1987). Because studies in patients often rely on small pieces of liver obtained from diverse anatomical locations, it seemed important to determine if the cytochromes P-450 were also heterogeneously distributed in human liver. Accordingly, tissue was obtained from ten different locations in a single human liver including those most commonly biopsied by percutaneous needles, and by surgeons during laparotomy. The differences observed between locations in the microsomal concentrations of carbon monoxide-binding protein (total cytochrome P-450), cytochrome b5, and NADPH-cytochrome P-450 reductase appeared to be small and were not statistically significant. Likewise, no significant differences were observed between locations in the specific content of HLp, HLp3, HLj, HLx or P450MP. However, the specific concentrations of HLd varied almost 2-fold between the microsomes and this was statistically significant in some cases (P < 0.05). Our results suggest that, in human livers, regional differences in the content of cytochromes P-450 are generally small but may be significant for some isozymes. With the exception of HLd, tissue obtained by percutaneous or surgical liver biopsies is probably representative of the entire organ with regard to the enzymes assayed. © 1990.
引用
收藏
页码:471 / 476
页数:6
相关论文
共 21 条
[1]   INVITRO STUDIES OF INDUCTION AND INHIBITION OF DRUG OXIDATION IN MAN [J].
BOOBIS, AR ;
MURRAY, S ;
SEDDON, CE ;
DAVIES, DS .
PHARMACOLOGY & THERAPEUTICS, 1987, 33 (01) :101-108
[2]   MONO-OXYGENASE ACTIVITY OF HUMAN-LIVER IN MICROSOMAL FRACTIONS OF NEEDLE-BIOPSY SPECIMENS [J].
BOOBIS, AR ;
BRODIE, MJ ;
KAHN, GC ;
FLETCHER, DR ;
SAUNDERS, JH ;
DAVIES, DS .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 9 (01) :11-19
[3]   INDUCTION OF DRUG-METABOLIZING-ENZYMES BY TRICYCLIC ANTI-DEPRESSANTS IN HUMAN-LIVER - CHARACTERIZATION AND PARTIAL RESOLUTION OF CYTOCHROMES P-450 [J].
CRESTEIL, T ;
CELIER, C ;
KREMERS, P ;
FLINOIS, JP ;
BEAUNE, P ;
LEROUX, JP .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 16 (06) :651-657
[4]   GENETICALLY-DETERMINED POLYMORPHISMS IN DRUG OXIDATION [J].
JACQZ, E ;
HALL, SD ;
BRANCH, RA .
HEPATOLOGY, 1986, 6 (05) :1020-1032
[5]   CRYSTALLINE CYTOCHROME B5 .I. PREPARATION OF CRYSTALLINE CYTOCHROME B5 FROM RABBIT LIVER [J].
KAJIHARA, T ;
HAGIHARA, B .
JOURNAL OF BIOCHEMISTRY, 1968, 63 (04) :453-&
[6]   HETEROGENEOUS DISTRIBUTION OF THE CYTOCHROME-P-450 MONO-OXYGENASE SYSTEM IN RAT-LIVER LOBES [J].
MATSUBARA, T ;
TOUCHI, A ;
OGAWA, A .
JAPANESE JOURNAL OF PHARMACOLOGY, 1982, 32 (06) :999-1011
[7]  
MAZEL P, 1971, FUNDAMENTALS DRUG ME, P546
[8]   THE P450 GENE SUPERFAMILY - RECOMMENDED NOMENCLATURE [J].
NEBERT, DW ;
ADESNIK, M ;
COON, MJ ;
ESTABROOK, RW ;
GONZALEZ, FJ ;
GUENGERICH, FP ;
GUNSALUS, IC ;
JOHNSON, EF ;
KEMPER, B ;
LEVIN, W ;
PHILLIPS, IR ;
SATO, R ;
WATERMAN, MR .
DNA-A JOURNAL OF MOLECULAR & CELLULAR BIOLOGY, 1987, 6 (01) :1-11
[9]  
NETER J, 1985, APPL LINEAR STAT MOD, P566
[10]  
OMURA T, 1964, J BIOL CHEM, V239, P2379